A detailed history of Bouchey Financial Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Bouchey Financial Group LTD holds 1,141 shares of LLY stock, worth $888,405. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,141
Previous 1,143 0.17%
Holding current value
$888,405
Previous $1.03 Million 2.32%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $1,544 - $1,920
-2 Reduced 0.17%
1,141 $1.01 Million
Q2 2024

Jul 12, 2024

SELL
$724.87 - $909.04 $39,867 - $49,997
-55 Reduced 4.59%
1,143 $1.03 Million
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $26,649 - $35,652
45 Added 3.9%
1,198 $931,000
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $501,209 - $690,992
1,153 New
1,153 $619,000
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $278,172 - $326,615
998 New
998 $324,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bouchey Financial Group LTD Portfolio

Follow Bouchey Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bouchey Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bouchey Financial Group LTD with notifications on news.